Bank of Montreal’s Adamas Pharmaceuticals ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-465,830
| Closed | -$2.4M | – | 4051 |
|
|
2021
Q3 | $2.4M | Buy |
465,830
+223,440
| +92% | +$1.09M | ﹤0.01% | 1983 |
|
|
2021
Q2 | $1.34M | Buy |
242,390
+66,303
| +38% | +$343K | ﹤0.01% | 2306 |
|
|
2021
Q1 | $808K | Buy |
176,087
+5,580
| +3% | +$29.1K | ﹤0.01% | 2354 |
|
|
2020
Q4 | $796K | Buy |
+170,507
| New | +$730K | ﹤0.01% | 2401 |
|
|
2020
Q1 | – | Sell |
-2,811
| Closed | -$11K | – | 4975 |
|
|
2019
Q4 | $11K | Buy |
2,811
+79
| +3% | +$378 | ﹤0.01% | 4556 |
|
|
2019
Q3 | $14K | Buy |
2,732
+803
| +42% | +$4.96K | ﹤0.01% | 4293 |
|
|
2019
Q2 | $12K | Buy |
1,929
+985
| +104% | +$5.67K | ﹤0.01% | 4464 |
|
|
2019
Q1 | $7K | Buy |
944
+627
| +198% | +$5.64K | ﹤0.01% | 3980 |
|
|
2018
Q4 | $3K | Buy |
317
+165
| +109% | +$2.15K | ﹤0.01% | 4314 |
|
|
2018
Q3 | $3K | Sell |
152
-4
| -3% | -$94 | ﹤0.01% | 4287 |
|
|
2018
Q2 | $4K | Buy |
+156
| New | +$4.32K | ﹤0.01% | 4208 |
|
|
2018
Q1 | – | Sell |
-1,288
| Closed | -$44K | – | 4421 |
|
|
2017
Q4 | $44K | Buy |
1,288
+288
| +29% | +$8.04K | ﹤0.01% | 3313 |
|
|
2017
Q3 | $21K | Hold |
1,000
| – | – | ﹤0.01% | 3507 |
|
|
2017
Q2 | $17K | Hold |
1,000
| – | – | ﹤0.01% | 3595 |
|
|
2017
Q1 | $18K | Hold |
1,000
| – | – | ﹤0.01% | 3415 |
|
|
2016
Q4 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 3483 |
|
|
2016
Q3 | $16K | Hold |
1,000
| – | – | ﹤0.01% | 3437 |
|
|
2016
Q2 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 3477 |
|
|
2016
Q1 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 3521 |
|
|
2015
Q4 | $28K | Sell |
1,000
-7,660
| -88% | -$129K | ﹤0.01% | 3277 |
|
|
2015
Q3 | $145K | Sell |
8,660
-19,046
| -69% | -$433K | ﹤0.01% | 2415 |
|
|
2015
Q2 | $727K | Buy |
27,706
+18,266
| +193% | +$355K | ﹤0.01% | 1802 |
|
|
2015
Q1 | $165K | Buy |
+9,440
| New | +$162K | ﹤0.01% | 2436 |
|
Bank of Montreal's ADMS Position: Q4 2021 in Review
Bank of Montreal sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 465,830 shares — an estimated $2.4M sold.
Bank of Montreal first reported a position in ADMS in Q1 2015 and held it in 23 quarters. The position peaked at $2.4M in Q3 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.
- Bank of Montreal reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- Bank of Montreal sold 465,830 Adamas Pharmaceuticals shares in Q4 2021, an estimated $2.4M.
- Bank of Montreal first reported a position in Adamas Pharmaceuticals in Q1 2015 and held it in 23 quarters.
- Bank of Montreal's Adamas Pharmaceuticals position peaked at $2.4M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.
Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.